Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Maintenance Therapy With Fluoropyrimidines, Immunotherapy or Targeted Therapies in Metastatic Gastric Cancer: A Retrospective Multicenter Study in High-Complexity Institutions in Latin America

NCT07856212 is registered in ClinicalTrials.gov with Fundación Santa Fe de Bogota as lead sponsor.

NCT NCT07856212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07856212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Maintenance Therapy With Fluoropyrimidines, Immunotherapy or Targeted Therapies in Metastatic Gastric Cancer: A Retrospective Multicenter Study in High-Complexity Institutions in Latin America
Lead sponsor
Fundación Santa Fe de Bogota
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2026
Completion date
March 1, 2027
Enrollment
150 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

gastric adenocarcinoma, metastatic gastric cancer, stomach neoplasms